Select a Region North America

EVERSANA Proudly Sponsors World Orphan Drug Congress

The Congress, held April 10-12 in Oxon Hill, MD, is the largest global annual gathering of orphan drug stakeholders focused on the evolving rare disease landscape. This year’s program has expanded to focus on cell and gene therapies for rare diseases as well as rare oncology, pricing and reimbursement, clinical development and regulatory, and advanced therapies in clinical and manufacturing.

On April 12, EVERSANA’s CEO Jim Lang leads esteemed industry colleagues in a panel discussion, “Improving Access and Affordability of New Orphan Drugs While Ensuring Continuous Investment in Rare Disease Innovation and R&D.” The panel discussion begins at 9:20 AM, and is part of the Rare Disease Advocacy World track of the Congress.

And, for the two days of the conference, EVERSANA business leaders will be at Booth 715 ready to talk about how our integrated services platform creates value by meeting patient, payer, and channel needs at every stage of the product lifecycle.